Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Sex-related differences in mast cell activity and doxorubicin toxicity: a study in spontaneously hypertensive rats.

Zhang J, Knapton A, Lipshultz SE, Cochran TR, Hiraragi H, Herman EH.

Toxicol Pathol. 2014;42(2):361-75. doi: 10.1177/0192623313482778. Epub 2013 Mar 26.

PMID:
23531790
2.

Differential cardiotoxicity in response to chronic doxorubicin treatment in male spontaneous hypertension-heart failure (SHHF), spontaneously hypertensive (SHR), and Wistar Kyoto (WKY) rats.

Sharkey LC, Radin MJ, Heller L, Rogers LK, Tobias A, Matise I, Wang Q, Apple FS, McCune SA.

Toxicol Appl Pharmacol. 2013 Nov 15;273(1):47-57. doi: 10.1016/j.taap.2013.08.012. Epub 2013 Aug 28.

PMID:
23993975
3.
4.

Comparison of the severity of the chronic cardiotoxicity produced by doxorubicin in normotensive and hypertensive rats.

Herman EH, el-Hage AN, Ferrans VJ, Ardalan B.

Toxicol Appl Pharmacol. 1985 Apr;78(2):202-14.

PMID:
4035676
5.

Time-course study on doxorubicin-induced nephropathy and cardiomyopathy in male and female LOU/M/Wsl rats: lack of evidence for a causal relationship.

van Hoesel QG, Steerenberg PA, Dormans JA, de Jong WH, de Wildt DJ, Vos JG.

J Natl Cancer Inst. 1986 Feb;76(2):299-307.

PMID:
3456068
6.

Correlation between serum levels of cardiac troponin-T and the severity of the chronic cardiomyopathy induced by doxorubicin.

Herman EH, Zhang J, Lipshultz SE, Rifai N, Chadwick D, Takeda K, Yu ZX, Ferrans VJ.

J Clin Oncol. 1999 Jul;17(7):2237-43.

PMID:
10561281
7.

[Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].

Jovanović DB, Jovović Dj, Varagić J, Dimitrijević J, Dragojlović Z, Djukanović L.

Srp Arh Celok Lek. 2002 Mar-Apr;130(3-4):73-80. Serbian.

8.
9.
10.

Comparison of the chronic toxicity of piroxantrone, losoxantrone and doxorubicin in spontaneously hypertensive rats.

Herman EH, Zhang J, Hasinoff BB, Tran KT, Chadwick DP, Clark JR Jr, Ferrans VJ.

Toxicology. 1998 Jun 26;128(1):35-52.

PMID:
9704904
11.

Peculiarities of adriamycin cardiotoxicity in spontaneously hypertensive rats (SHR).

Herrmann HJ, Massow S, Moritz V, Norden C, Kühne C.

Biomed Biochim Acta. 1987;46(8-9):S593-6.

PMID:
3435516
12.

Dose-response relationship of dexrazoxane for prevention of doxorubicin-induced cardiotoxicity in mice, rats, and dogs.

Imondi AR, Della Torre P, Mazué G, Sullivan TM, Robbins TL, Hagerman LM, Podestà A, Pinciroli G.

Cancer Res. 1996 Sep 15;56(18):4200-4.

13.
14.
15.

NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).

National Toxicology Program .

Natl Toxicol Program Tech Rep Ser. 1993 Sep;422:1-340.

16.

Comparison of the protective effects of amifostine and dexrazoxane against the toxicity of doxorubicin in spontaneously hypertensive rats.

Herman EH, Zhang J, Chadwick DP, Ferrans VJ.

Cancer Chemother Pharmacol. 2000;45(4):329-34.

PMID:
10755322
17.

Reproductive hormone levels and differential mitochondria-related oxidative gene expression as potential mechanisms for gender differences in cardiosensitivity to Doxorubicin in tumor-bearing spontaneously hypertensive rats.

Gonzalez Y, Pokrzywinski KL, Rosen ET, Mog S, Aryal B, Chehab LM, Vijay V, Moland CL, Desai VG, Dickey JS, Rao VA.

Cancer Chemother Pharmacol. 2015 Sep;76(3):447-59. doi: 10.1007/s00280-015-2786-8. Epub 2015 Jun 25.

PMID:
26108538
18.

Use of cardiac troponin T levels as an indicator of doxorubicin-induced cardiotoxicity.

Herman EH, Lipshultz SE, Rifai N, Zhang J, Papoian T, Yu ZX, Takeda K, Ferrans VJ.

Cancer Res. 1998 Jan 15;58(2):195-7.

20.

The use of serum levels of cardiac troponin T to compare the protective activity of dexrazoxane against doxorubicin- and mitoxantrone-induced cardiotoxicity.

Herman EH, Zhang J, Rifai N, Lipshultz SE, Hasinoff BB, Chadwick DP, Knapton A, Chai J, Ferrans VJ.

Cancer Chemother Pharmacol. 2001 Oct;48(4):297-304.

PMID:
11710630

Supplemental Content

Support Center